Community/Retail

Alex Barker, PharmD, founder of Pharmacy School HQ, is a self-proclaimed "neopharmaphobic" clinical pharmacist in Michigan.

The FDA has approved a single-use lens delivery system for patients undergoing cataract surgery.

This Breast Cancer Awareness Month, Pfizer Inc. and the Union for International Cancer Control (UICC) are proud to announce the recipients from the Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge.

Pharmacists are making a real difference in their communities and having a significant impact on the health care team.

ASHP has convened a group of thought leaders to explore the unique barriers, challenges, and issues facing women in the workforce.

According to the 2015 National Community Pharmacists Association's Digest, achieving both higher patient adherence to prescription medication and more diversified pharmacy revenue streams are vital to the future success of independent community pharmacies.

SilverScript Insurance Company has announced its new Medicare Prescription Drug Plan options for 2016.

The Rite Aid Foundation is making a $25,000 donation to the Palmetto South Carolina Region chapter of the American Red Cross to help the victims, families and communities affected by last week's severe flooding.

As part of their Diabetes Awareness Month activities, supermarket partners Ralphs and Food 4 Less will conduct a check stand donation program to benefit the American Diabetes Association

Understanding why anti-vaxxers stand against vaccination may help pharmacists develop strategies to remove barriers to immunization.

Pharmacists can advocate for health literacy among patients, so they should also be able to advocate for their financial literacy.

The National Institutes of Health (NIH) has awarded universities about $28 million in grants to study pediatric asthma triggers.

The FDA recently approved a new treatment for a rare condition called hereditary orotic aciduria.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses how compounding laws vary from state to state.

The first shipments of much-needed hemophilia therapy have started to arrive at treatment centers across the developing world.

The FDA is considering expanding the use of Allergen's skin infection drug dalbavancin (Dalvance).

Did you know that the 14% of undiagnosed HIV patients cause 33% of new infections?

In recognition of their commitment to improving medication adherence, John Sykora and Dr. Jan Kavookjian were honored at the National Community Pharmacists Association's (NCPA) 2015 Annual Convention at the Gaylord National Resort & Convention Center held from Oct. 10 -14.

How to avoid the curse of becoming invisible to your community.

Boehringer Ingelheim and Philogen will collaborate on investigating novel treatment approaches for Acute Myeloid Leukemia.

Why are drug prices so high in the United States?

Pharmacists can help patients understand what they are finding online.

Cardiovascular disease (CVD) is the most common cause of death in America, but the disease rates for African-Americans are especially high.

Brian Beach, RPh of the Kelley-Ross Pharmacy Group in Seattle, Washington was named the winner of the National Community Pharmacists Association (NCPA) 2015 Prescription Drug Safety Award.

You don't have to be an artist or ad man to come up with an idea, paint a picture, and capture someone's attention.

Joe Moose, RPh, co-owner of Moose Pharmacy and its multiple locations in and around Concord, N.C., has been named the National Community Pharmacists Association (NCPA) 2015 Willard B. Simmons Independent Pharmacist of the Year.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several successful patient counseling techniques with respect to improved medication adherence.

Upsher-Smith Laboratories was honored today with the National Community Pharmacists Association (NCPA) 2015 Corporate Recognition Award.

Patients with concomitant atrial fibrillation (AF) and heart failure (HF) face worse symptoms, poorer prognoses, and different treatment responses than those with either condition alone.